WASHINGTON--(BUSINESS WIRE)--The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of new drugs to fight tuberculosis (TB), announced at the Global Health Council Conference today that four drug discovery collaboration agreements have been signed. All four projects have the potential to generate compounds active against drug-resistant tuberculosis and show promise to advance the science of TB drug development.
